RETINA-AI offers an AI-powered solution for screening Diabetic Retinopathy. The system enables immediate screening with results in under 10 seconds, eliminating the need for on-site eye care specialists. Using deep learning, it effectively detects moderate or worse diabetic retinopathy (mowDRet) in patients, ensuring timely referrals for treatment. Designed for ease of use, the tool can be operated by trained medical assistants, requiring minimal training. It accommodates various robotic cameras, enhancing workflow in clinics. Additionally, the product aims to improve healthcare access and reduce costs by enabling fast assessments in primary care environments. The AI's sensitivity exceeds 90% for detecting diabetic retinopathy, making it a reliable choice for preventive healthcare.
• provides actionable report
• enhances access to care
• easy training for clinic staff
• high sensitivity for disease detection
• same-day test results
• fda clearance pending
• compatible with multiple robotic cameras
• no human grader required
• diagnosis in under 10 seconds
• immediate diabetic retinopathy screening
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
A federated AI framework that integrates decentralized data sources for AI development.
View Details